1
|
O6-[(2″,3″-O-Isopropylidene-5″-O-tbutyldimethylsilyl)pentyl]-5′-O-tbutyldiphenylsilyl-2′,3′-O-isopropylideneinosine. MOLBANK 2022. [DOI: 10.3390/m1345] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Cyclic adenosine diphosphate ribose (cADPR) is a cyclic nucleotide involved in the Ca2+ homeostasis. In its structure, the northern ribose, bonded to adenosine through an N1 glycosidic bond, is connected to the southern ribose through a pyrophosphate bridge. Due to the chemical instability at the N1 glycosidic bond, new bioactive cADPR derivatives have been synthesized. One of the most interesting analogues is the cyclic inosine diphosphate ribose (cIDPR), in which the hypoxanthine replaced adenosine. The efforts for synthesizing new linear and cyclic northern ribose modified cIDPR analogues led us to study in detail the inosine N1 alkylation reaction. In the last few years, we have produced new flexible cIDPR analogues, where the northern ribose has been replaced by alkyl chains. With the aim to obtain the closest flexible cIDPR analogue, we have attached to the inosine N1 position a 2″,3″-dihydroxypentyl chain, possessing the two OH groups in a ribose-like fashion. The inosine alkylation reaction afforded also the O6-alkylated regioisomer, which could be a useful intermediate for the construction of new kinds of cADPR mimics.
Collapse
|
2
|
D'Errico S, Greco F, Patrizia Falanga A, Tedeschi V, Piccialli I, Marzano M, Terracciano M, Secondo A, Roviello GN, Oliviero G, Borbone N. Probing the Ca 2+ mobilizing properties on primary cortical neurons of a new stable cADPR mimic. Bioorg Chem 2021; 117:105401. [PMID: 34662754 DOI: 10.1016/j.bioorg.2021.105401] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2021] [Revised: 09/08/2021] [Accepted: 09/11/2021] [Indexed: 01/06/2023]
Abstract
Cyclic adenosine diphosphate ribose (cADPR) is a second messenger involved in the Ca2+ homeostasis. Its chemical instability prompted researchers to tune point by point its structure, obtaining stable analogues featuring interesting biological properties. One of the most challenging derivatives is the cyclic inosine diphosphate ribose (cIDPR), in which the hypoxanthine isosterically replaces the adenine. As our research focuses on the synthesis of N1 substituted inosines, in the last few years we have produced new flexible cIDPR analogues, where the northern ribose has been replaced by alkyl chains. Interestingly, some of them mobilized Ca2+ ions in PC12 cells. To extend our SAR studies, herein we report on the synthesis of a new stable cIDPR derivative which contains the 2″S,3″R dihydroxypentyl chain instead of the northern ribose. Interestingly, the new cyclic derivative and its open precursor induced an increase in intracellular calcium concentration ([Ca2+]i) with the same efficacy of the endogenous cADPR in rat primary cortical neurons.
Collapse
Affiliation(s)
- Stefano D'Errico
- Dipartimento di Farmacia, Università degli Studi di Napoli Federico II, via Domenico Montesano, 49-80131 Napoli, Italy
| | - Francesca Greco
- Dipartimento di Farmacia, Università degli Studi di Napoli Federico II, via Domenico Montesano, 49-80131 Napoli, Italy
| | - Andrea Patrizia Falanga
- Dipartimento di Farmacia, Università degli Studi di Napoli Federico II, via Domenico Montesano, 49-80131 Napoli, Italy
| | - Valentina Tedeschi
- Dipartimento di Neuroscienze, Scienze Riproduttive e Odontostomatologiche, Divisione di Farmacologia, Università degli Studi di Napoli Federico II, Via Sergio Pansini, 5-80131 Napoli, Italy
| | - Ilaria Piccialli
- Dipartimento di Neuroscienze, Scienze Riproduttive e Odontostomatologiche, Divisione di Farmacologia, Università degli Studi di Napoli Federico II, Via Sergio Pansini, 5-80131 Napoli, Italy
| | - Maria Marzano
- Istituto di Cristallografia (IC) CNR, Via Amendola 122/O-70126, Bari, Italy
| | - Monica Terracciano
- Dipartimento di Farmacia, Università degli Studi di Napoli Federico II, via Domenico Montesano, 49-80131 Napoli, Italy
| | - Agnese Secondo
- Dipartimento di Neuroscienze, Scienze Riproduttive e Odontostomatologiche, Divisione di Farmacologia, Università degli Studi di Napoli Federico II, Via Sergio Pansini, 5-80131 Napoli, Italy
| | | | - Giorgia Oliviero
- Dipartimento di Medicina Molecolare e Biotecnologie Mediche, via Sergio Pansini, 5-80131 Napoli, Italy.
| | - Nicola Borbone
- Dipartimento di Farmacia, Università degli Studi di Napoli Federico II, via Domenico Montesano, 49-80131 Napoli, Italy
| |
Collapse
|
3
|
Shuto S. [Medicinal Chemical Studies Based on the Theoretical Design of Bioactive Compounds]. YAKUGAKU ZASSHI 2020; 140:329-344. [PMID: 32115550 DOI: 10.1248/yakushi.19-00208] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
I have engaged in medicinal chemical studies based on the theoretical design of bioactive compounds. First, I present a three-dimensional structural diversity-oriented conformational restriction strategy for developing bioactive compounds based on the characteristic steric and stereoelectronic features of cyclopropane. Using this strategy, various biologically active small molecule compounds, such as receptor agonists/antagonists and enzyme inhibitors, were effectively developed. The strategy was also applied to develop versatile peptidomimetics and membrane-permeable cyclic peptides. Next, studies on Ca2+-mobilizing second messengers, cyclic ADP-ribose (cADPR) and myo-inositol trisphosphates (IP3), are described. In these studies, stable equivalents of cADPR were developed, since biological studies of cADPR have been limited due to its instability. Various potent IP3 receptor ligands, which were designed using the d-glucose structure as a bioisostere of the myo-inositol moiety of IP3, have been identified. Organic chemistry studies have also been extensively performed, because excellent organic chemistry is essential for promoting high-level medicinal chemical studies. For examples, new methods for the synthesis of chiral cyclopropanes, new radical reactions with silicon tethers, and kinetic anomeric effect-dependent stereoselective glycosidations have been developed.
Collapse
Affiliation(s)
- Satoshi Shuto
- Faculty of Pharmaceutical Sciences, Hokkaido University
| |
Collapse
|
4
|
Shuto S. Cyclic ADP-Carbocyclic-Ribose and -4-Thioribose, as Stable Mimics of Cyclic ADP-Ribose, a Ca 2+-Mobilizing Second Messenger. Chem Pharm Bull (Tokyo) 2018; 66:155-161. [PMID: 29386466 DOI: 10.1248/cpb.c17-00668] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Cyclic ADP-ribose (cADPR), a general mediator involved in Ca2+ signaling, has the characteristic 18-membered ring consisting of an adenine, two riboses and a pyrophosphate, in which the two primary hydroxy groups of the riboses are linked by a pyrophosphate unit. This review focuses on chemical synthetic studies of cADPR analogues of biological importance. Although cADPR analogues can be synthesized by enzymatic and chemo-enzymatic methods using ADP-ribosyl cyclase, the analogues obtained by these methods are limited due to the substrate-specificity of the enzymes. Consequently, chemical synthetic methods providing a greater variety of cADPR analogues are required. Although early chemical synthetic studies demonstrated that construction of the large 18-membered ring structure is difficult, the construction was achieved using the phenylthiophosphate-type substrates by treating with AgNO3 or I2. This is now a general method for synthesizing these types of biologically important cyclic nucleotides. Using this method as the key step, the chemically and biologically stable cADPR mimic, cADP-carbocyclic-ribose (cADPcR) and -4-thioribose (cADPtR), were synthesized.
Collapse
Affiliation(s)
- Satoshi Shuto
- Faculty of Pharmaceutical Sciences, Hokkaido University
| |
Collapse
|
5
|
Takano S, Tsuzuki T, Murayama T, Kameda T, Kumaki Y, Sakurai T, Fukuda H, Watanabe M, Arisawa M, Shuto S. Synthesis of 8-Substituted Analogues of Cyclic ADP-4-Thioribose and Their Unexpected Identification as Ca 2+-Mobilizing Full Agonists. J Med Chem 2017. [PMID: 28636353 DOI: 10.1021/acs.jmedchem.7b00540] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
A series of 8-substituted analogues of cyclic ADP-4-thioribose (cADPtR, 3), which is a stable equivalent of Ca2+-mobilizing second messenger cyclic ADP-ribose (cADPR, 1), were designed as potential pharmacological tools for studies on cADPR-modulated Ca2+ signaling pathways. These 8-amino analogue (8-NH2-cADPtR, 4), 8-azido analogue (8-N3-cADPtR, 5), and 8-chloro analogue (8-Cl-cADPtR, 6) were efficiently synthesized, where the stereoselective N1-β-thioribosyladenine ring closure reaction via an α/β-equilibrium of the 1-aminothioribose derivative and construction of the characteristic 18-membered pyrophosphate ring by Ag+-promoted activation of a phenyl phosphorothioate type substrate were the two key steps. Although 8-NH2-cADPR (2) is a well-known potent antagonist against cADPR-inducing Ca2+-release, the 4-thioribose congener 8-NH2-cADPtR turned out unexpectedly to be a full agonist in sea urchin egg homogenate evaluation system. This important finding suggested that the ring-oxygen in the N1-ribose of cADPR analogues is essential for the antagonistic activity in the Ca2+-signaling pathway, which can contribute to clarify the structure-agonist/antagonist activity relationship.
Collapse
Affiliation(s)
| | | | - Takashi Murayama
- Department of Pharmacology, Juntendo University School of Medicine , Bunkyo-ku, Tokyo 113-8421, Japan
| | - Tomoshi Kameda
- Computational Biology Research Center, National Institute of Advanced Industrial Science and Technology (AIST) , Aomi, Koutou-ku, Tokyo 135-0064, Japan
| | - Yasuhiro Kumaki
- Faculty of Sciences, Hokkaido University , Kita-11, Nishi-8, Kita-ku, Sapporo 060-0812, Japan
| | - Takashi Sakurai
- Department of Pharmacology, Juntendo University School of Medicine , Bunkyo-ku, Tokyo 113-8421, Japan
| | | | | | | | | |
Collapse
|